Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Drug interactions between ixabepilone and Stamaril

Results for the following 2 drugs:
ixabepilone
Stamaril (yellow fever vaccine)

Interactions between your drugs

Major

yellow fever vaccine ixabepilone

Applies to: Stamaril (yellow fever vaccine) and ixabepilone

If you are currently being treated or have recently been treated with ixabepilone, you should let your doctor know before receiving yellow fever vaccine. Depending on the dose and length of time you have been on ixabepilone, you may be at risk for developing an infection from the vaccine or have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of ixabepilone therapy. Conversely, if you have recently been vaccinated with yellow fever vaccine, your doctor may choose to postpone treatment with ixabepilone for a few weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

Moderate

ixabepilone food

Applies to: ixabepilone

Do not consume grapefruit or grapefruit juice during treatment with ixabepilone unless specifically directed otherwise by your doctor. Ixabepilone can interact with grapefruit and grapefruit juice and the interaction may increase the effects of ixabepilone. You should discuss the use of grapefruit and grapefruit juice with your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide